David Boulware, MD MPH@boulware_drIn designing the trial, we were aware that treatment choices become politicized, thus we wanted a flexible trial such that people would be willing to participate even if they did not like drug A but liked drug B, C, and D.8:48 PM · Oct 22, 20222 Likes